...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Cancer Commences Operations !!!??
Sorry, you're probably right. I know people don't always read everything thoroughly. I just thought it would help put some of the pieces together since we've been through this before. I won't do it again. PVLee
Share
New Message
Please login to post a reply